Breadcrumb Home Studies Studies Search Filter Research Area AllComplications & ComorbiditiesCureTreatmentTuberculosis Study Status AllClosed to AccrualClosed to Follow UpConcludedEnrollingIn DevelopmentParticipants Off Study and Primary Analysis CompletedPending Sort Study Number AscStudy Number Desc Submit Search Showing 26 studies. P1068S: Parasitemia And Clinical Malaria In Children On Protease-Inhibitor-Based Therapy DAIDS Number 10661 Research Area Other Study Status Concluded P1066: Raltegravir Safety, Tolerability, PK, & Antiretroviral Activity DAIDS Number 10495 Research Area Treatment Study Status Concluded P1065: Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine in HIV-Infected Youth (Versions 1.0 - 3.0) and Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth (Version 4.0) DAIDS Number 10396 Research Area Other Study Status Concluded P1063: Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of Increased LDL-Cholesterol in HIV-Infected children, Adolescents, and Young Adults DAIDS Number 10167 Research Area Complications & Comorbidities Study Status Concluded P1058A: Pharmacokinetics of New Classes of Antiretroviral Drug Combinations DAIDS Number 10809 Research Area Other Study Status Concluded P1025: Perinatal Core Protocol DAIDS Number 10039 Research Area Prevention Study Status Concluded Pagination Previous page Prev Page 1 Page 2 Current page 3
P1068S: Parasitemia And Clinical Malaria In Children On Protease-Inhibitor-Based Therapy DAIDS Number 10661 Research Area Other Study Status Concluded
P1066: Raltegravir Safety, Tolerability, PK, & Antiretroviral Activity DAIDS Number 10495 Research Area Treatment Study Status Concluded
P1065: Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine in HIV-Infected Youth (Versions 1.0 - 3.0) and Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth (Version 4.0) DAIDS Number 10396 Research Area Other Study Status Concluded
P1063: Phase I/II Safety and Efficacy Investigation of Atorvastatin for Treatment of Increased LDL-Cholesterol in HIV-Infected children, Adolescents, and Young Adults DAIDS Number 10167 Research Area Complications & Comorbidities Study Status Concluded
P1058A: Pharmacokinetics of New Classes of Antiretroviral Drug Combinations DAIDS Number 10809 Research Area Other Study Status Concluded
